Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.Simcere Pharmaceutical Group Limited先声药业集团有限公司 (Incorporated in Hong Kong with limited liability) (Stock code: 2096) (I) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 14 2024 AND (II) PAYMENT OF FINAL DIVIDEND Reference is made to the notice (the “AGM Notice”) of the annual general meeting (the “AGM” or “Meeting”) and the circular (the “Circular”) of Simcere Pharmaceutical Group Limited (the “Company”) both dated May 24 2024. Unless the context requires otherwise terms used herein shall have the same meanings as those defined in the Circular.(I) POLL RESULTS OF AGM The board of directors of the Company (the “Board”) is pleased to announce that the AGM was held on June 14 2024 at 9:00 a.m. and the proposed resolutions as set out in the AGM Notice (the “Resolutions”) were duly passed by the shareholders of the Company (the “Shareholder(s)”) by way of poll. The poll results in respect of the Resolutions are as follows: Number of votes (%) Ordinary Resolutions For Against 1. To receive consider and adopt the audited 1652658270 374000 consol ida ted f inancia l s ta tements of the (99.977375%) (0.022625%) Company and the reports of the directors of the Company (the “Director(s)”) and auditors of the Company (the “Auditors”) for the year ended December 31 2023.– 1 –Number of votes (%) Ordinary Resolutions For Against 2. (a) To declare a final dividend of RMB0.16 1653031270 1000 per ordinary share of the Company (the (99.999940%) (0.000060%) “Final Dividend”) for the year ended December 31 2023.(b) Any Director be and is hereby authorised 1653031270 1000 to take such action do such things and (99.999940%) (0.000060%) execute such further documents as the Director may at his/her absolute discretion consider necessary or desirable for the purpose of or in connection with the implementation of the payment of the Final Dividend. 3. (a) To re-elect the following retiring Directors: i. Mr. REN Jinsheng as an executive 1637084554 15947716 Director; (99.035245%) (0.964755%) ii. Mr. SONG Ruilin as an independent 1649958547 3073723 non-executive Director; and (99.814055%) (0.185945%) iii. Mr. WANG Jianguo as an independent 1652586005 446265 non-executive Director. (99.973003%) (0.026997%) (b) To authorise the board of the Directors to 1652233537 798733 fix the remuneration of the Directors. (99.951681%) (0.048319%) 4. To re-appoint KPMG as the Auditors and 1652658270 374000 authorise the board of the Directors to fix their (99.977375%) (0.022625%) remuneration. 5. To grant a general mandate to the Directors 1597744181 55288089 to allot issue and deal with the securities of (96.655353%) (3.344647%) the Company not exceeding 20% of the total number of shares of the Company in issue as at the date of the Meeting.– 2 –Number of votes (%) Ordinary Resolutions For Against 6. To grant a general mandate to the Directors to 1652658270 374000 repurchase the securities of the Company not (99.977375%) (0.022625%) exceeding 10% of the total number of shares of the Company in issue as at the date of the Meeting. 7. To extend conditional upon the passing of 1597371181 55661089 resolutions 5 and 6 the total number of shares (96.632789%) (3.367211%) of the Company repurchased under resolution 6 to the mandate granted to the directors under resolution 5.As more than 50% of the votes attaching to the shares of the Company (the “Share(s)”) held by the Shareholders present and voting in person or by proxy at the AGM were cast in favour of each of the Resolutions the Resolutions were duly passed as the ordinary resolutions.As at the date of the AGM the total number of Shares in issue was 2609761618 Shares.The total number of Shares entitling the holders to attend and vote on the resolution at the AGM was 2609761618 Shares. There were no Shares entitling the holder to attend and abstain from voting in favour of the Resolutions at the AGM as set out in rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”).No Shareholder was required under the Listing Rules to abstain from voting on the Resolutions at the AGM. None of the Shareholders have stated their intention in the Circular to vote against or to abstain from voting on the Resolutions at the AGM.Computershare Hong Kong Investor Services Limited the share registrar of the Company in Hong Kong was appointed as the scrutineer at the AGM for the purpose of vote-taking.All Directors (including Mr. REN Jinsheng as the Chairman and executive Director; Mr.TANG Renhong Mr. WAN Yushan and Ms. WANG Xi as the executive Directors; and Mr. SONG Ruilin Mr. WANG Jianguo Mr. WANG Xinhua and Mr. SUNG Ka Woon as the independent non-executive Directors) attended the AGM.– 3 –(II) PAYMENT OF THE FINAL DIVIDEND The payment of the Final Dividend of RMB0.16 per Share for the year ended December 31 2023 was approved at the AGM. The Final Dividend is denominated and declared in Renminbi and payable in HK dollars to Shareholders. The actual amount declared in HK dollars is converted based on the average central parity rate of Renminbi against HK dollars as promulgated by the People’s Bank of China for the five business days preceding the date of the AGM at HK$1 against RMB0.91064 being a cash dividend of HK$0.17570 per share.The Final Dividend will be paid on or before Monday July 15 2024 to the Shareholders whose names appear on the register of members of the Company on Tuesday June 25 2024. The register of members of the Company will be closed from Thursday June 20 2024 to Tuesday June 25 2024 (both days inclusive) for the purpose of determining the entitlements to the Final Dividend for the year ended December 31 2023. The record date will be Tuesday June 25 2024. In order to qualify for the Final Dividend all transfer forms accompanied by the relevant share certificates must be lodged with the Company’s share registrar in Hong Kong Computershare Hong Kong Investor Services Limited at Shops 1712–1716 17th Floor Hopewell Centre 183 Queen’s Road East Wanchai Hong Kong not later than 4:30 p.m. on Wednesday June 19 2024.By order of the Board Simcere Pharmaceutical Group Limited Mr. Ren Jinsheng Chairman and Chief Executive Officer Hong Kong June 14 2024 As at the date of this announcement the Board comprises Mr. REN Jinsheng as the Chairman and executive Director; Mr. TANG Renhong Mr. WAN Yushan and Ms. WANG Xi as the executive Directors; and Mr. SONG Ruilin Mr. WANG Jianguo Mr. WANG Xinhua and Mr.SUNG Ka Woon as the independent non-executive Directors.–4–